offline
Stryker (SYK) Q4 Earnings and Revenues Surpass Estimates
Stryker Corporation SYK reported fourth-quarter 2019 adjusted earnings per share (EPS) of $2.49, which beat the Zacks Consensus Estimate by 1.2%. Further, the bottom line improved 14.2% year over year and exceeded the high end of management’s guidance range.
The Michigan-based medical device company reported revenues of $4.13 billion, which outpaced the Zacks Consensus Estimate by 0.7%. Revenues improved 8.8% on a year-over-year basis and 9.4% at constant currency (cc).
2019 at a Glance
In 2019, the company reported revenues worth $14.88 billion, which beat the Zacks Consensus Estimate. On a year-over-year basis, the top line improved 9.4%.
Adjusted EPS for the year was $8.26, which beat the Zacks Consensus Estimate by 0.4%. The bottom line also increased 13% year over year.
...
https://finance.yahoo.com/news/stryker-s...01712.html
![[Bild: SYKc1dl1601.png]](https://finviz.com/publish/012920/SYKc1dl1601.png)
Stryker Corporation SYK reported fourth-quarter 2019 adjusted earnings per share (EPS) of $2.49, which beat the Zacks Consensus Estimate by 1.2%. Further, the bottom line improved 14.2% year over year and exceeded the high end of management’s guidance range.
The Michigan-based medical device company reported revenues of $4.13 billion, which outpaced the Zacks Consensus Estimate by 0.7%. Revenues improved 8.8% on a year-over-year basis and 9.4% at constant currency (cc).
2019 at a Glance
In 2019, the company reported revenues worth $14.88 billion, which beat the Zacks Consensus Estimate. On a year-over-year basis, the top line improved 9.4%.
Adjusted EPS for the year was $8.26, which beat the Zacks Consensus Estimate by 0.4%. The bottom line also increased 13% year over year.
...
https://finance.yahoo.com/news/stryker-s...01712.html
__________________
